SK

Stephen Knight

Managing Partner at F

Cambridge, Massachusetts

Overview

Work Experience

F-Prime Capital (formerly Fidelity Biosciences)

  • President & Managing Partner

    2003 - Current

    A global venture capital firm investing in healthcare and technology, with a heritage that spans four decades. - See more at: http://fprimecapital.com/#sthash.ukRtLCJW.dpuf

EPIX Pharmaceuticals

  • President, COO

    1996 - 2003

AD

Arthur D. Little

  • Consultant

    1991 - 1996

AT&T Bell Laboratories

  • Junior Researcher

    1985 - 1985

Education

Investments

Quantum Circuits

Series B

Total Funding: $78M

Genomics

Series B

Total Funding: $84M

Paradigm

Series A

Total Funding: $240M

Ensoma

Series A

Total Funding: $210M

Latest Articles

Medium•Dec. 2018

OCE featured at Canadian Rural Innovation Summit in Belleville

Talks about Canada, Ontario and Rural

Medium•Nov. 2018

Adopting industry-leading software

Talks about Manufacturing, Automotive and Automation

Medium•Nov. 2018

Using white light to scan future growth

Talks about 3D Printing, Auto and Technology

Medium•Oct. 2017

Making your morning joe a sustainable brew

Talks about Environment, Ontario and Manufacturing

Relevant Websites